Literature DB >> 25246148

Altered serum cytokine signature in common variable immunodeficiency.

Zdenek Hel1, Richard P H Huijbregts, Jun Xu, Jana Nechvatalova, Marcela Vlkova, Jiri Litzman.   

Abstract

PURPOSE: Common variable immunodeficiency (CVID) is the most frequent form of primary symptomatic hypogammaglobulinemia. CVID patients display a number of abnormalities in lymphocyte subpopulations including chronic T-cell activation and decreased numbers of circulating CD4(+) T cells and NK cells. We and others have recently shown that CVID is associated with increased concentration of soluble CD14 (sCD14) and other factors indicating limited microbial translocation.
METHODS: To address the mechanisms of chronic immune activation in CVID, we performed a detailed analysis of cytokine serum levels in 36 patients with CVID, 52 patients with selective IgA deficiency (IgAD), and 56 healthy volunteers.
RESULTS: We show that CVID is associated with elevated serum levels of CXCL-10/IP-10, IL-1R antagonist, TNF-α, IL-10, IL-12 (p40), CCL-2/MCP-1, G-CSF, and CCL-11/eotaxin. The detected cytokine signature is consistent with an ongoing activation of cells of myeloid lineage. In contrast, the levels of cytokines typically produced by CD4(+) T helper cells of Th1 (IFN-γ, IL-2), Th2 (IL-9, IL-13), and Th17 (IL-17) subtypes were suppressed in CVID patients compared to healthy donors.
CONCLUSIONS: Presented data suggest that the altered cytokine profile observed in patients with CVID may be attributed to the activation of monocyte-macrophage and granulocyte lineages, possibly driven by the translocation of bacterial components across the gastrointestinal or respiratory tracts mucosal barrier.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25246148      PMCID: PMC4870003          DOI: 10.1007/s10875-014-0099-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  51 in total

1.  Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency.

Authors:  R Cambronero; W A Sewell; M E North; A D Webster; J Farrant
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency.

Authors:  J Litzman; M Vlková; Z Pikulová; D Stikarovská; J Lokaj
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

3.  Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation.

Authors:  U Bank; D Reinhold; C Schneemilch; D Kunz; H J Synowitz; S Ansorge
Journal:  J Interferon Cytokine Res       Date:  1999-11       Impact factor: 2.607

4.  A novel role of metalloproteinase in cancer-mediated immunosuppression.

Authors:  B C Sheu; S M Hsu; H N Ho; H C Lien; S C Huang; R H Lin
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

Review 5.  Biology of interleukin-10.

Authors:  Robert Sabat; Gerald Grütz; Katarzyna Warszawska; Stefan Kirsch; Ellen Witte; Kerstin Wolk; Jens Geginat
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-05       Impact factor: 7.638

6.  The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.

Authors:  Osamu Shimozato; Shin-ichi Ugai; Masako Chiyo; Hisanori Takenobu; Hiroyasu Nagakawa; Akihiko Wada; Kiyoko Kawamura; Hiroshi Yamamoto; Masatoshi Tagawa
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

7.  CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients.

Authors:  Junyan Han; Beibei Wang; Ning Han; Yan Zhao; Chuan Song; Xin Feng; Yu Mao; Fujie Zhang; Hongxin Zhao; Hui Zeng
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

8.  Modulation by interferon-gamma of the production and gene expression of IL-1 receptor antagonist in human neutrophils.

Authors:  P P McDonald; S Gasperini; F Calzetti; M A Cassatella
Journal:  Cell Immunol       Date:  1998-02-25       Impact factor: 4.868

Review 9.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

10.  IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.

Authors:  Thomas Reiberger; Judith H Aberle; Michael Kundi; Norbert Kohrgruber; Armin Rieger; Alfred Gangl; Heidemarie Holzmann; Markus Peck-Radosavljevic
Journal:  Antivir Ther       Date:  2008
View more
  12 in total

1.  Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation.

Authors:  Clairelyne Dupin; Sylvain Marchand-Adam; Olivier Favelle; Romain Costes; Philippe Gatault; Philippe Diot; Leslie Grammatico-Guillon; Laurent Guilleminault
Journal:  J Clin Immunol       Date:  2016-10-06       Impact factor: 8.317

Review 2.  Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.

Authors:  Dominic Paquin-Proulx; Johan K Sandberg
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

3.  Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia.

Authors:  Jan Stuchlý; Veronika Kanderová; Marcela Vlková; Ivana Heřmanová; Lucie Slámová; Ondřej Pelák; Eli Taraldsrud; Dalibor Jílek; Pavlína Králíc Ková; Børre Fevang; Marie Trková; Ondřej Hrušák; Eva Froňková; Anna Šedivá; Jiří Litzman; Tomáš Kalina
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

4.  Total and High Molecular Weight Adiponectin Expression Is Decreased in Patients with Common Variable Immunodeficiency: Correlation with Ig Replacement Therapy.

Authors:  Antonio Pecoraro; Ersilia Nigro; Rita Polito; Maria Ludovica Monaco; Olga Scudiero; Ilaria Mormile; Azzurra Cesoni Marcelli; Mario Capasso; Francesco Habetswallner; Arturo Genovese; Aurora Daniele; Giuseppe Spadaro
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

5.  A Novel Monoallelic Nonsense Mutation in the NFKB2 Gene Does Not Cause a Clinical Manifestation.

Authors:  Jerzy Kotlinowski; Karolina Bukowska-Strakova; Agnieszka Koppolu; Joanna Kosińska; Natalia Pydyn; Piotr Stawinski; Mateusz Wilamowski; Witold Nowak; Alicja Józkowicz; Jarosław Baran; Rafał Płoski; Jolanta Jura
Journal:  Front Genet       Date:  2019-02-26       Impact factor: 4.599

6.  Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency.

Authors:  Magnhild E Macpherson; Bente Halvorsen; Arne Yndestad; Thor Ueland; Tom E Mollnes; Rolf K Berge; Azita Rashidi; Kari Otterdal; Ida Gregersen; Xiang Y Kong; Kirsten B Holven; Pål Aukrust; Børre Fevang; Silje F Jørgensen
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

7.  IL-10-Producing Regulatory B Cells Are Decreased in Patients with Common Variable Immunodeficiency.

Authors:  Nathalia Silveira Barsotti; Rafael Ribeiro Almeida; Priscilla Ramos Costa; Myrthes Toledo Barros; Jorge Kalil; Cristina Maria Kokron
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

8.  Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.

Authors:  Camila de Lollo; Dewton de Moraes Vasconcelos; Luanda Mara da Silva Oliveira; Tiago de Oliveira Titz; Magda Carneiro-Sampaio; Cristina Miuki Abe Jacob; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  J Transl Med       Date:  2016-05-17       Impact factor: 5.531

9.  Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy.

Authors:  Rita Polito; Ersilia Nigro; Antonio Pecoraro; Maria Ludovica Monaco; Franco Perna; Alessandro Sanduzzi; Arturo Genovese; Giuseppe Spadaro; Aurora Daniele
Journal:  Front Immunol       Date:  2019-11-27       Impact factor: 7.561

Review 10.  Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders.

Authors:  Antonio Pecoraro; Ludovica Crescenzi; Gilda Varricchi; Giancarlo Marone; Giuseppe Spadaro
Journal:  Front Immunol       Date:  2020-02-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.